Correction: Cost of illness of chronic kidney disease in Lebanon: from the societal and third-party payer perspectives

被引:0
|
作者
Mabel Aoun
Elie Helou
Ghassan Sleilaty
Rony M. Zeenny
Dania Chelala
机构
[1] Saint-Joseph University,Department of Nephrology, Faculty of Medicine
[2] Saint-George Hospital,Department of Nephrology
[3] Saint-Joseph University,Department of Urology, Faculty of Medicine
[4] Saint-Joseph University,Unit of biostatistics, Faculty of Medicine
[5] Pharmacy Director,Department of Nephrology at Hotel
[6] American University of Beirut Medical Center,Dieu de France Hospital, Faculty of Medicine
[7] Saint-Joseph University,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Cost effectiveness of antihypertensive monotherapy with perindopril or enalapril in elderly patients from the third party payer perspective
    Hermanowski, T
    Jaworski, R
    Czech, M
    Pachocki, R
    VALUE IN HEALTH, 2004, 7 (06) : 691 - 691
  • [22] Adult lifetime cost of hemophilia B management in the US: payer and societal perspectives from a decision analytic model
    Li, Nanxin
    Sawyer, Eileen K.
    Maruszczyk, Konrad
    Guzauskas, Greg
    Slomka, Marta T.
    Burke, Tom
    Martin, Antony P.
    O'Hara, Jamie
    Stevenson, Matt
    Recht, Michael
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 363 - 372
  • [23] Systematic Review of the Cost of Illness of Parkinson's Disease from a Societal Perspective
    Wijers, Anke
    Ravi, Anirudhan
    Evers, Silvia M. A. A.
    Tissingh, Gerrit
    van Mastrigt, Ghislaine A. P. G.
    MOVEMENT DISORDERS, 2024,
  • [24] Cost-utility and budget impact analysis of CPAP therapy compared to no treatment in the management of moderate to severe obstructive sleep apnea in Colombia from a third-party payer perspective
    Robles, Antonio
    Gil-Rojas, Yaneth
    Amaya, Devi
    Hernandez, Fabian
    Escobar-Cordoba, Franklin
    Venegas, Marco
    Amado, Steve
    Restrepo-Gualteros, Sonia
    Echeverry, Jorge
    Marin, Fernando
    Zabala, Sandra
    Angelica Bazurto-Zapata, Maria
    Deger, Melike
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (04) : 399 - 407
  • [25] COST-EFFECTIVENESS ANALYSIS OF DULAGLUTIDE COMPARED WITH INSULIN GLARGINE ADD ON TO INSULIN LISPRO IN TREATMENT OF TYPE 2 DIABETES: A US THIRD-PARTY PAYER PERSPECTIVE
    Nili, M.
    Wu, W.
    Kumar, A.
    VALUE IN HEALTH, 2016, 19 (03) : A203 - A203
  • [26] THE COST OF CHRONIC KIDNEY DISEASE BEFORE RENAL REPLACEMENT THERAPY IN MOROCCO: A COST OF ILLNESS STUDY
    Alaoui, Amina Chrifi
    Omari, Mohammed
    Qarmiche, Noura
    Kouiri, Omar
    Chouhani, Basmat Amal
    Houssaini, Tarik Sqalli
    El Fakir, Samira
    Tachfouti, Nabil
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 : 316 - 316
  • [27] "COST OF ILLNESS" ANALYSIS OF CHRONIC KIDNEY DISEASE IN THE ENTIRE POPULATION OF THE RUSSIAN FEDERATION
    Kulikov, A.
    Serpik, V. G.
    Abdrashitova, G.
    VALUE IN HEALTH, 2015, 18 (03) : A187 - A187
  • [28] CHRONIC KIDNEY DISEASE IN TYPE 2 DIABETES IN COLOMBIA: A COST OF ILLNESS ANALYSIS
    Mayorga, W.
    Lopez, D. S.
    Patino, A.
    Zuluaga, J. R.
    Alvarado, A.
    Marrugo, R.
    Lopez, C.
    VALUE IN HEALTH, 2022, 25 (07) : S337 - S338
  • [29] COST-EFFECTIVENESS OF APREPITANT IN EGYPTIAN PATIENTS RECEIVING HIGHLY EMETOGENIC THERAPY FROM THE THIRD PARTY PAYER PERSPECTIVE
    Helal, M.
    Elsisi, G.
    VALUE IN HEALTH, 2014, 17 (07) : A634 - A634
  • [30] Industry expectations of supply chain management graduates: Perspectives from third-party logistics providers in South Africa
    Allden, Marc
    Niemann, Wesley
    Kotze, Theuns
    JOURNAL OF TRANSPORT AND SUPPLY CHAIN MANAGEMENT, 2018, 12